In bladder cancer, PD-L1 is predominantly expressed in tumor-infiltrating immune cells rather than in the tumor cells themselves, and its expression level shows a significant correlation with high-grade T1 stage tumor progression (Dallos and Drake, 2018; Wankowicz et al., 2017). This evidence concerns the gene CD274 and urinary bladder carcinoma.